• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗相关心功能障碍乳腺癌患者的生活质量:一项定性研究。

Quality of life in breast cancer patients with cancer treatment-related cardiac dysfunction: a qualitative study.

机构信息

Department of Cardiology, Radboud University Medical Center, Geert Grooteplein 10 - route 616, 6500 HB Nijmegen, the Netherlands.

Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Geert Grooteplein 10 - route 114, 6500 HB Nijmegen, the Netherlands.

出版信息

Eur J Cardiovasc Nurs. 2022 Apr 9;21(3):235-242. doi: 10.1093/eurjcn/zvab057.

DOI:10.1093/eurjcn/zvab057
PMID:34252175
Abstract

BACKGROUND

Although improved breast cancer (BC) treatment has decreased mortality, these anti-cancer regimens may have serious cardiovascular side effects that affect patients' long-term prognosis and quality of life (QoL). BC patients with cancer treatment-related cardiac dysfunction (CTRCD) can suffer from a variety of symptoms, such as dyspnoea and fatigue. The impact of CTRCD after BC treatment on patients' daily life has not been qualitatively explored yet.

AIMS

This study aims to explore the influence of CTRCD on QoL of women with BC, as defined by the concept of positive health. Second, we aim to evaluate the personal experience with cardiac surveillance during the BC trajectory.

METHODS AND RESULTS

A qualitative study with semi-structured interviews was conducted and thematically analysed to explore the QoL and healthcare experiences of BC patients with CTRCD. Twelve patients participated in this study. Five themes are selected in response to the study objective: (i) patients: overwhelming fatigue, (ii) patients: mental burden of anxiety, (iii) social setting: lack of understanding and acceptance, (iv) medical specialists: lack of knowledge and acknowledgement, and (v) patients: need for personalized care.

CONCLUSION

This study identified core components of the impact CTRCD has on the QoL of BC patients. Patients experienced an increased health-related burden due to CTRCD, affecting their physical, social, and psychosocial well-being. Healthcare experiences were largely affected by a lack of acknowledgement and professional communication. Patients underlined the need for personalized care during follow-up.

摘要

背景

尽管乳腺癌(BC)治疗方法的改进降低了死亡率,但这些抗癌疗法可能会产生严重的心血管副作用,影响患者的长期预后和生活质量(QoL)。患有与癌症治疗相关的心脏功能障碍(CTRCD)的 BC 患者可能会出现多种症状,如呼吸困难和疲劳。BC 治疗后 CTRCD 对患者日常生活的影响尚未得到定性探讨。

目的

本研究旨在通过积极健康的概念来探讨 CTRCD 对 BC 女性生活质量的影响。其次,我们旨在评估 BC 病程中心脏监测的个人体验。

方法和结果

进行了一项半结构式访谈的定性研究,并进行了主题分析,以探讨患有 CTRCD 的 BC 患者的生活质量和医疗保健体验。共有 12 名患者参与了这项研究。针对研究目的,选择了五个主题:(i)患者:压倒性的疲劳,(ii)患者:焦虑的精神负担,(iii)社会环境:缺乏理解和接受,(iv)医学专家:缺乏知识和认可,以及(v)患者:需要个性化护理。

结论

本研究确定了 CTRCD 对 BC 患者生活质量影响的核心组成部分。患者因 CTRCD 而增加了与健康相关的负担,影响了他们的身体、社会和心理社会福祉。医疗保健体验在很大程度上受到缺乏认可和专业沟通的影响。患者强调了在随访期间需要个性化护理。

相似文献

1
Quality of life in breast cancer patients with cancer treatment-related cardiac dysfunction: a qualitative study.癌症治疗相关心功能障碍乳腺癌患者的生活质量:一项定性研究。
Eur J Cardiovasc Nurs. 2022 Apr 9;21(3):235-242. doi: 10.1093/eurjcn/zvab057.
2
Oncology professionals' perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study.肿瘤学专业人士对高心脏毒性风险乳腺癌患者心脏监测的看法:一项定性研究。
PLoS One. 2021 Mar 31;16(3):e0249067. doi: 10.1371/journal.pone.0249067. eCollection 2021.
3
Arterial Stiffness May Predict Subsequent Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Patients.动脉僵硬度可能预测乳腺癌患者后续癌症治疗相关的心脏功能障碍。
Cardiovasc Toxicol. 2024 Apr;24(4):375-384. doi: 10.1007/s12012-024-09841-w. Epub 2024 Mar 8.
4
Impact of the COVID-19 pandemic on women living with and beyond breast cancer: a qualitative study of women's experiences and how they varied by social determinants of health.COVID-19 大流行对患有乳腺癌和乳腺癌康复后的女性的影响:一项定性研究,探讨了女性的经历以及健康社会决定因素对其经历的影响。
BMC Cancer. 2023 Sep 15;23(1):867. doi: 10.1186/s12885-023-11351-x.
5
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
6
The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review.运动在预防接受化疗的乳腺癌患者癌症治疗相关心脏功能障碍中的作用:系统评价。
Eur J Prev Cardiol. 2022 Mar 25;29(3):463-472. doi: 10.1093/eurjpc/zwab006.
7
Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.心室-动脉耦合和圆周应变的非侵入性测量可预测癌症治疗相关的心脏功能障碍。
JACC Cardiovasc Imaging. 2016 Oct;9(10):1131-1141. doi: 10.1016/j.jcmg.2015.11.024. Epub 2016 Apr 13.
8
The impact of physical activity on fatigue and quality of life during and after adjuvant treatment for breast cancer.体力活动对乳腺癌辅助治疗期间和治疗后疲劳和生活质量的影响。
Cancer. 2018 Feb 15;124(4):797-806. doi: 10.1002/cncr.31108. Epub 2017 Nov 8.
9
Cancer or no cancer: the influence of trait anxiety and diagnosis on quality of life with breast cancer and benign disease: a prospective, longitudinal study.癌症或无癌症:特质焦虑和诊断对乳腺癌和良性疾病患者生活质量的影响:一项前瞻性、纵向研究。
World J Surg. 2013 Sep;37(9):2140-7. doi: 10.1007/s00268-013-2088-4.
10
A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews.一种乳腺癌治疗后康复干预的综合方法——系统评价的系统综述。
BMC Cancer. 2019 May 20;19(1):472. doi: 10.1186/s12885-019-5648-7.

引用本文的文献

1
Cardiotoxicity in Breast Cancer Therapy: Risks, Mechanisms, and Prevention Strategies.乳腺癌治疗中的心脏毒性:风险、机制及预防策略。
Med Sci (Basel). 2025 Aug 14;13(3):130. doi: 10.3390/medsci13030130.
2
Prevention of cancer-therapy related cardiac dysfunction.癌症治疗相关心脏功能障碍的预防。
Curr Heart Fail Rep. 2025 Feb 19;22(1):9. doi: 10.1007/s11897-025-00697-x.
3
HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction.
HER-SAFE研究设计:一项开放标签、随机对照试验,旨在调查恢复的HER2靶向治疗相关心脏功能障碍停药的安全性。
BMJ Open. 2025 Feb 5;15(2):e091917. doi: 10.1136/bmjopen-2024-091917.
4
Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease.重新评估抗炎治疗:靶向衰老以平衡抗癌疗效和血管疾病
Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):372-385. doi: 10.1161/ATVBAHA.124.319870. Epub 2025 Jan 16.
5
Weight Changes and Heart Failure Risk After Breast Cancer Development.乳腺癌发生后的体重变化与心力衰竭风险
JAMA Oncol. 2025 Mar 1;11(3):342-345. doi: 10.1001/jamaoncol.2024.5803.
6
A Systematic Review of the Cardiotoxic Effects of Targeted Therapies in Oncology.肿瘤靶向治疗心脏毒性作用的系统评价
Cureus. 2024 Aug 6;16(8):e66258. doi: 10.7759/cureus.66258. eCollection 2024 Aug.
7
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer.反向 FASN 和 LDHA 相关驱动乳腺癌代谢抵抗。
J Transl Med. 2024 Jul 24;22(1):676. doi: 10.1186/s12967-024-05517-9.
8
Risk and Management of Patients with Cancer and Heart Disease.癌症与心脏病患者的风险及管理
Cardiol Ther. 2023 Jun;12(2):227-241. doi: 10.1007/s40119-023-00305-w. Epub 2023 Feb 9.
9
Incidence and Related Factors for Low-Extremity Deep Vein Thrombosis in Breast Cancer Patients Who Underwent Surgical Resection: What Do We Know and What Should We Care.接受手术切除的乳腺癌患者下肢深静脉血栓形成的发生率及相关因素:我们知道什么以及应该关注什么
Front Surg. 2022 Feb 4;9:755671. doi: 10.3389/fsurg.2022.755671. eCollection 2022.
10
Oncology professionals' perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study.肿瘤学专业人士对高心脏毒性风险乳腺癌患者心脏监测的看法:一项定性研究。
PLoS One. 2021 Mar 31;16(3):e0249067. doi: 10.1371/journal.pone.0249067. eCollection 2021.